Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

Patent 12071432 was granted and assigned to Deciphera Pharmaceuticals on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Deciphera Pharmaceuticals

Current Assignee

Deciphera Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120714320

Patent Inventor Names

Timothy Caldwell0

Yu Mi Ahn0

Lakshminarayana Vogeti0

Daniel L. Flynn0

Date of Patent

August 27, 2024

Patent Application Number

178332720

Date Filed

June 6, 2022

Patent Citations

‌

US Patent 7173028 Pyrimidine derivatives

‌

US Patent 7202257 Anti-inflammatory medicaments

‌

US Patent 7253174 N-heterocyclic inhibitors of TNF-α expression

‌

US Patent 7276510 HIV replication inhibitors

‌

US Patent 7279576 Anti-cancer medicaments

‌

US Patent 7342037 Anti-inflammatory medicaments

‌

US Patent 7364656 Triazine-based detoxification agents and their use

‌

US Patent 7442705 HIV replication inhibiting pyrimidines and triazines

...

Patent Primary Examiner

CPC Code

Patent abstract

Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API